Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers
NCT ID: NCT00312364
Last Updated: 2012-06-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
322 participants
INTERVENTIONAL
2005-12-31
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients participating in the study may receive an active drug (MRE0094), inactive drug (placebo), or a gel used to treat diabetic foot ulcers currently available for sale in the United States. What treatment a patient will receive is determined by chance (like drawing a number from a hat). All patients will receive additional care for diabetic foot ulcers during the study.
Participation in the study can be up to 4½ months.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers
NCT00318214
A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)
NCT01154374
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
NCT02833389
A Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor for Induction of Healing of Diabetic Foot Ulcers
NCT00351767
Nu-3 Gel for Infected Diabetic Foot Ulcers
NCT06020235
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRE0094
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have type 1 or type 2 diabetes mellitus.
* Have problems with the nerves in their feet.
* Have an ulcer on the bottom surface of their foot that has been present for 3 weeks or more and is of sufficient size to qualify for the study.
* Be able to apply study drug to their ulcer, or have a caregiver do it.
* Be able to visit the doctor regularly during the 4½ month study.
Exclusion Criteria
* Their ulcer is caused by bad blood flow to their foot.
* Their ulcer is infected.
* They cannot wear a special boot during the study to take pressure off the ulcer.
* They have certain other diseases, or are using certain types of drugs.
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute for Advanced Wound Care
Montgomery, Alabama, United States
Palo Verde Foot and Ankle
Bullhead City, Arizona, United States
Carl T. Hayden VA Medical Center
Phoenix, Arizona, United States
Associated Foot & Ankle Specialists, LLC
Phoenix, Arizona, United States
Aung Foot Health Clinics & Advanced Wound Care
Tucson, Arizona, United States
Southern Arizona VA Health Care System
Tucson, Arizona, United States
Vertex Clinical Research
Bakersfield, California, United States
Roy O. Kroeker, DPM
Fresno, California, United States
Innovative Medical Technologies
Los Angeles, California, United States
UCSD Wound Treatment and Research Center
San Diego, California, United States
Bay Area Foot Care
San Francisco, California, United States
Walter F. D'Costa, DPM
Santa Rosa, California, United States
Diabetic Foot & Wound Center
Denver, Colorado, United States
North American Center for Limb Preservation
New Haven, Connecticut, United States
Christiana Care Health Systems Wound Care Center
Wilmington, Delaware, United States
Countryside Foot and Ankle Center
Clearwater, Florida, United States
Karr Foot & Leg Centers
Lakeland, Florida, United States
University of Miami
Miami, Florida, United States
Baptist Hospital
Pensacola, Florida, United States
Doctor's Research Network
South Miami, Florida, United States
Dr. Robert J. Snyder
Tamarac, Florida, United States
Ankle and Foot Specialist of Atlanta
Lithonia, Georgia, United States
Podiatry Center of Idaho, PLLC
Boise, Idaho, United States
Adam S. Landsman, DPM, PhD, FACFAS
Highland Park, Illinois, United States
Advocate Lutheran General Hospital
Niles, Illinois, United States
North Chicago VA Medical Center
North Chicago, Illinois, United States
Thomas Kevin Brattain, DPM
Peoria, Illinois, United States
Carle Foundation Hospital
Urbana, Illinois, United States
Welborn Clinic
Evansville, Indiana, United States
The Wound Healing Center
Terre Haute, Indiana, United States
Dolby Research, LLC
Baton Rouge, Louisiana, United States
David Fivenson, MD, Dermatology, PLLC
Ann Arbor, Michigan, United States
Foot Healthcare Associates
Livonia, Michigan, United States
Northern Michigan Hospital
Petoskey, Michigan, United States
Foot & Ankle Physicians
Union, New Jersey, United States
St. John's Queens Hospital
Elmhurst, New York, United States
North Shore Podiatry Group
Port Jefferson Station, New York, United States
Calvary Hospital
The Bronx, New York, United States
Upstate Clinical Research Associates
Williamsville, New York, United States
UNC Wound Care Clinic
Durham, North Carolina, United States
Eastern Carolina Foot & Ankle Specialists
Greenville, North Carolina, United States
Bone, Spine, Sports Center
Bismarck, North Dakota, United States
Austintown Podiatry Associates, Inc.
Austintown, Ohio, United States
New Horizons Clinical Research
Cincinnati, Ohio, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Optimed Research, LLC
Columbus, Ohio, United States
Lehigh Valley Podiatry Associates
Allentown, Pennsylvania, United States
Advanced Regional Center for Ankle and Foot Care
Altoona, Pennsylvania, United States
UPMC Horizon
Farrell, Pennsylvania, United States
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
Foot and Ankle Institute
Philadelphia, Pennsylvania, United States
Prigoff-Bowers, LLP
Dallas, Texas, United States
Limb Salvage Center
Dallas, Texas, United States
South Texas Foot Institute
Floresville, Texas, United States
Memorial Hermann Wound Center
Houston, Texas, United States
Southwest Regional Wound Care Center
Lubbock, Texas, United States
Barrett Quality Medical Interests, LP
San Antonio, Texas, United States
San Antonio Podiatry Associates, PC
San Antonio, Texas, United States
Richard G. Seegmiller, DPM
Bountiful, Utah, United States
Douglas C. Flegal, DMP, FACFAS
Salt Lake City, Utah, United States
Atlantic Foot & Ankle Center
Virginia Beach, Virginia, United States
Madigan Army Medical Center
Tacoma, Washington, United States
St. Luke's Medical Center
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MRE0094P-201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.